Frank Szulzewsky

19PUBLICATIONS
48CO-AUTHORS
Gene and molecular therapyMolecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMaterials conservation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 03, 2026
Comprehensive analysis of TEAD inhibition in meningioma identifies MEK and mTOR inhibition as effective combination therapies against resistant lines.

Dylan J Keiser, Meghan S Buddy, Solmaz Mojarad-Jabali

|Feb 10, 2026
A systems approach identifies MERTK as a therapeutic vulnerability in ZFTA-RELA-driven ependymomas.

Marina Chan, Songli Zhu, Zachary R Russell

|Jan 07, 2026
PTEN deficiency linked to chromosome 10q loss leads to aggressive NF2 mutant meningioma biology.

Abigail G Parrish, H Nayanga Thirimanne, Sonali Arora

|Jul 16, 2025
Development of PROTACs for targeted degradation of oncogenic TRK fusions.

Saurav Kumar, Jiewei Jiang, Mia S Donald-Paladino

|Apr 28, 2025
C-terminal fusion partner activity contributes to the oncogenic functions of YAP1::TFE3.

Patrick J Cimino, Dylan J Keiser, Abigail G Parrish

|Feb 13, 2025
RNA polymerase II at histone genes predicts outcome in human cancer.

Steven Henikoff, Ye Zheng, Ronald M Paranal

Pageof 4